beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?
Page
R L
RL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D003657:Decision Making; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006325:Heart Atria / Q000187:drug effects / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D055502:Secondary Prevention
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants